3//SEC Filing
CureDuchenne Ventures, LLC 3
Accession 0000899243-20-025437
CIK 0001818794other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 8:44 PM ET
Size
4.5 KB
Accession
0000899243-20-025437
Insider Transaction Report
Form 3
CureDuchenne Ventures, LLC
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (602,972 underlying)
Footnotes (1)
- [F1]The Series A Preferred Stock is convertible into common stock on a 3.3169-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001824590
Filing Metadata
- Form type
- 3
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 8:44 PM ET
- Size
- 4.5 KB